Understanding and Treating Blood Cancers
Hematologic Malignancies
This program aims to better understand blood cancers like leukemia and lymphoma to find new ways to diagnose and treat them.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11099849 on NIH RePORTER |
What this research studies
Our program brings together experts from various fields to explore the causes of blood cancers, identify markers that help monitor the disease, and develop new treatments. We focus on translating discoveries from the lab directly to patient care, and also learn from patient samples to guide our laboratory work. This collaborative approach helps us make progress in diagnosing and treating complex blood disorders, with a strong emphasis on moving new ideas into clinical practice. Our team has a history of leading clinical trials that have resulted in new FDA-approved therapies.
Who could benefit from this research
Good fit: Patients with blood cancers such as Acute Myeloid Leukemia (AML) and B-Cell Chronic Lymphocytic Leukemia (CLL) are the focus of this research.
Not a fit: Patients without a diagnosis of hematologic malignancies would not directly benefit from this specific research program.
Why it matters
Potential benefit: If successful, this program could lead to improved diagnostic tools and new, more effective therapies for patients with various blood cancers.
How similar studies have performed: This program builds on a strong history of translational research, with members having led clinical trials that resulted in several FDA-approved therapies.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Levy, Ronald — Stanford University
- Study coordinator: Levy, Ronald
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.